Current status of medical and surgical therapy for obesity

Gastroenterology

Volumn 120, Issue 3, 2001, Pages 669-681

  Mun, Edward C ^a   Blackburn, George L ^a   Matthews, Jeffrey B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DEXFENFLURAMINE; FENFLURAMINE; LEPTIN; PHENTERMINE; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ADDICTION; BEHAVIOR THERAPY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; HEART DISEASE; HUMAN; OBESITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; STOMACH BYPASS; SURGICAL APPROACH; WEIGHT REDUCTION;

EID: 0035112424     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.22430     Document Type: Article

References (132)

1. Appetite and the regulation of body composition
2. A twin study of human obesity
3. An adoption study of human obesity
4. Genetic and environmental correlations between obesity and body fat distribution in adult male twins
5. Overweight and obesity in the United States: Prevalence and trends, 1960-1994
6. Overweight prevalence among youth in the United States: Why so many different numbers?
7. The disease burden associated with overweight and obesity
8. The spread of the obesity epidemic in the United States, 1991-1998
9. Annual deaths attributable to obesity in the United States
10. Can anyone successfully control their weight? Finding of a three year community-based study of men and women
11. Body weight and mortality. A 27-year follow-up of middle-aged men
12. Body weight and mortality among women
13. Body mass index and patterns of mortality among Seventh-day Adventist men
14. The effect of age on the association between body-mass index and mortality
15. Body-mass index and mortality in a prospective cohort of U.S. adults
16. Positional cloning of the mouse obese gene and its human homologue
17. Effects of the obese gene product on body weight regulation in ob/ob mice
18. Congenital leptin deficiency is associated with severe early-onset obesity in humans
19. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
20. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
21. Towards a molecular understanding of adaptive thermogenesis
22. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y
23. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome
24. Central nervous system control of food intake
25. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans
26. A frameshift mutation in MC4R associated with dominantly inherited human obesity
27. Structure-function relationship in UCP1
28. Structure and function of the uncoupling protein from brown adipose tissue
29. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis
30. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area
31. Leptin increases uncoupling protein expression and energy expenditure
32. Excessive mortality and causes of death in morbidly obese men
33. Mortality of severely obese subjects
34. The surgical treatment of morbid obesity
35. Obesity and hypertension: Epidemiological and clinical issues
36. Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: The Oslo Diet and Exercise Study (ODES)
37. Randomized clinical trials of weight reduction in nonhypertensive persons
38. Diet and exercise are equally effective in reducing risk for cardiovascular disease. Results of a randomized controlled study in men with slightly to moderately raised cardiovascular risk factors
39. Effect of an American Heart Association diet, with or without weight loss, on lipids in obese middle-aged and older men
40. Group education for obese patients with type 2 diabetes: Greater success at less cost
41. Life style changes improve insulin resistance in hyperinsulinaemic subjects: A one-year intervention study of hypertensives and normotensives in Dalby
42. A randomized controlled trial of weight reduction and exercise for diabetes management in older African-American subjects
43. Impact of gastric restrictive surgery on hypertension in the morbidly obese
44. The effect of gastric bypass surgery on hypertension in morbidly obese patients
45. Effects of weight reduction after gastroplasty on glucose and lipid metabolism
46. Gastric bariatric operation in insulin-treated adults
47. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus
48. Hemodynamic dysfunction in obesity hypoventilation syndrome and the effects of treatment with surgically induced weight loss
49. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity
50. Severe reflux esophagitis after vertical banded gastroplasty for treatment of morbid obesity
51. Conversion of failed or complicated vertical banded gastroplasty to gastric bypass in morbid obesity
52. Reversal of benign intracranial hypertension by surgically induced weight loss
53. Differentiated long-term effects of intentional weight loss on diabetes and hypertension
54. Loss of weight, sodium and water in obese persons consuming a high- or low-carbohydrate diet
55. Postingestional effects of a high-protein diet on the regulation of food intake in monkeys
56. Similar weight loss with low- or high-carbohydrate diets
57. A public health approach to the problem of obesity
58. Group- vs home-based exercise training in healthy older men and women. A community-based clinical trial
59. The effect of weight loss by dieting or exercise on resting metabolic rate in overweight men
60. Effects of exercise on cardiovascular disease risk in women with NIDDM
61. Weight loss in obese women - Exercise v. dietary education
62. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise
63. Maintenance and relapse after weight loss in women: Behavioral aspects
64. Behavioral treatment of obesity
65. Controlled trial of very low calorie diet, behavior therapy, and their combination in the treatment of obesity
66. One-year behavioral treatment of obesity: Comparison of moderate and severe caloric restriction and the effects of weight maintenance therapy
67. Behavior therapy and pharmacotherapy for obesity
68. Lifestyle modification in the pharmacologic treatment of obesity: A pilot investigation of a potential primary care approach
69. Use and abuse of appetite-suppressant drugs in the treatment of obesity
70. Valvular heart disease associated with fenfluramine-phentermine
71. International trial of long-term dexfenfluramine in obesity
72. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination
73. Long-term weight control: The National Heart, Lung, and Blood Institute funded multimodal intervention study
74. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation
75. The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs
76. An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo
77. Sibutramine reduces food intake in non-dieting women with obesity
78. Thermogenic effects of sibutramine in humans
79. Effects of sibutramine on resting metabolic rate and weight loss in overweight women
80. A comparison of sibutramine and dexfenfluramine in the treatment of obesity
81. Long-term maintenance of weight loss after a very-low-calorie diet: A randomized blinded trial of the efficacy and tolerability of sibutramine
82. Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin)
83. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
84. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: A randomized controlled trial
85. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: A 1-y study
86. Enhanced thermogenic responsiveness during chronic ephedrine treatment in man
87. The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women
88. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial
89. The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans
90. Identification of the major intestinal fatty acid transport protein
91. NIH conference: Gastrointestinal surgery for severe obesity
92. Surgical treatment of obesity
93. Jejunoileal bypass for morbid obesity. A critical appraisal
94. Morphologic liver changes in intestinal bypass patients
95. Gastric surgery for morbid obesity
96. Biliopancreatic diversion for obesity at eighteen years
97. Malabsorptive procedures for severe obesity: Comparison of pancreaticobiliary bypass and very very long limb Roux-en-Y gastric bypass
98. Biliopancreatic diversion with a new type of gastrectomy: Some previous conclusions revisited
99. Biliopancreatic diversion, with distal gastrectomy, 250 cm and 50 cm limbs: Long-term results
100. Biliopancreatic diversion with duodenal switch
101. Gastroplasty in morbid obesity
102. Gastric partitioning for morbid obesity
103. Vertical banded gastroplasty for obesity
104. Results of the surgical treatment of obesity
105. Prospective evaluation of vertical banded gastroplasty as the primary operation for morbid obesity
106. Gastric bypass and vertical banded gastroplasty - A prospective randomized comparison and 5-year follow-up
107. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters
108. Experience with the Roux-en-Y gastric bypass, and commentary on current trends
109. Gastric banding, a surgical method of treating morbid obesity: Preliminary report
110. Stoma adjustable silicone gastric banding
111. Laparoscopic placement of adjustable silicone gastric band in the treatment of morbid obesity: How to do it
112. Prospective study of a laparoscopically placed, adjustable gastric band in the treatment of morbid obesity
113. Laparoscopic adjustable gastric banding
114. Adjustable gastric banding: 5-Year experience
115. The Swedish Adjustable Gastric Banding (SAGB) for morbid obesity: 9 Year experience and a 4-year follow-up of patients operated with a new adjustable band
116. Silicone-adjustable gastric banding: Disappointing results
117. Gastric bypass
118. Experimental studies on gastric bypass versus standard ulcer operations
119. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity
120. Gastric and jejunoileal bypass. A comparison in the treatment of morbid obesity
121. Long-limb gastric bypass in the superobese. A prospective randomized study
122. Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation
123. Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty
124. Weight loss with vertical banded gastroplasty and Roux-Y gastric bypass for morbid obesity with selective versus random assignment
125. Laparoscopic gastric bypass, roux-en-Y: Preliminary report of five cases
126. Hand-assisted laparoscopic digestive surgery provides safety and tactile sensation for malignancy or obesity
127. Laparoscopic roux-en-Y gastric bypass: A case report at one-year follow-up
128. Laparoscopic roux-en-Y gastric bypass: A totally intra-abdominal approach - Technique and preliminary report
129. Laparoscopic gastric bypass, Roux-en-Y - 500 patients: Technique and results, with 3-60 month follow-up